2963-LB: Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2963-lb ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von YING LI und 11 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction and Objective: Diabetes prevalence is high and increases all-cause, cardiovascular diseases (CVDs), and cancer mortality risk. This study investigates the association between Life's Essential 8 (LE8) and these mortality risks, and diabetes' potential modifying effect.
Methods
We analyzed 20,231 US adults (3,497 with diabetes; 16,724 without) from National Health and Nutrition Examination Survey (NHANES) 2005-2018. LE8 scores (0-100) were categorized by weighted tertiles.Cox proportional hazards regression models assessed associations with prospectively tracked mortality (through 2019).
Results
Over median 7.2 years, 1920 all-cause, 472 CVD, and 484 cancer deaths occurred. Mortality rates were higher in people with diabetes. Within the people without diabetes, a 10-point increment in the LE8 Score was linked to a significant 23% decrease in the risk of all-cause mortality (HR=0.77, 95% CI: 0.67-0.90), a 21% decrease in the risk of CVD mortality (HR=0.79, 95% CI: 0.64-0.98). However, no significant association was detected between LE8 Score and cancer mortality in people with diabetes (HR=0.89, 95% CI: 0.70-1.13). In non-diabetic population, the HRs for LE8 and all-cause, CVD, cancer mortality were 0.58(95% CI: 0.44-0.75), 0.63(95% CI: 0.40-0.98), 0.64(95% CI: 0.42-0.97). There was a synergistic additive interaction between diabetes and LE8 score on CVD death (RERI: 0.56, 95% CI: 0.04-1.09; AP: 0.30, 95% CI: 0.04-0.57; S: 2.91, 95% CI: 0.54-15.69).
Conclusion
Higher LE8 score conferred greater mortality risk reduction in people with diabetes compared to people without diabetes. Diabetes and suboptimal LE8 scores might synergistically accelerate CVD death, underscoring the necessity for dual interventions addressing both glycemic control and cardiovascular health optimization in this population. Disclosure Y. Li: None. Y. Chu: None. A. Abudukeranmu: None. Z. Pang: None. Y. Zhuang: None. J. Chang: None. H. Fan: None. J. Li: None. P. Li: None. M. Li: None. Z. Song: None. H. Zhu: None.
Zitieren
APA
LI, Y., CHU, Y., ABUDUKERANMU, A., PANG, Z., ZHUANG, Y., CHANG, J., FAN, H., LI, J., LI, P., LI, M., SONG, Z., & ZHU, H. (2026). 2963-LB: Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2963-lb
Vancouver
LI Y, CHU Y, ABUDUKERANMU A, PANG Z, ZHUANG Y, CHANG J, et al. 2963-LB: Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2963-lb
BibTeX
@article{LI2026,
author = {LI, YING and CHU, YUTING and ABUDUKERANMU, ADILAN and PANG, ZHIXIN and ZHUANG, YAXU and CHANG, JINGDAN and FAN, HANBING and LI, JINNAN and LI, PENGCHENG and LI, MINGZHEN and SONG, ZHENQIANG and ZHU, HONG},
title = {2963-LB: Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2963-lb}
}
EUVIMED